Related Experiment Video
Updated: Jun 14, 2025

09:45
Author Spotlight: Advancing Syphilis Research — Innovations in Treponema pallidum Cultivation and Genetic Engineering
Published on: January 24, 2025
3.5K
Advances in Syphilis Diagnostics to Address the 21st-Century Epidemic
Rebecca S Treger1, Tim W Menza2,3, Thao T Truong1
1Department of Laboratory Medicine and Pathology, University of Washington, School of Medicine, Seattle, WA, United States.
Clinical Chemistry
|June 13, 2025
Summary
Syphilis cases have surged 30-fold since 2000, with over 209,000 cases in 2023. New diagnostics and public health efforts like doxycycline post-exposure prophylaxis are key to controlling this sexually transmitted infection.
Area of Science:
- Infectious Diseases
- Epidemiology
- Clinical Microbiology
Background:
- The United States faces a syphilis epidemic, with cases rising over 30-fold since 2000 to over 209,000 in 2023.
- Congenital syphilis cases have increased tenfold in the last decade, highlighting challenges in disease control.
- Factors hindering syphilis containment include treatment shortages, antibiotic resistance, and diagnostic limitations.
Purpose of the Study:
- To review current epidemiologic trends of syphilis in the US.
- To discuss gold-standard and emerging diagnostic methods for syphilis detection.
- To identify key challenges faced by laboratorians in managing syphilis.
Main Methods:
- Review of epidemiologic data on syphilis trends.
- Analysis of current and novel diagnostic techniques.
- Examination of challenges in syphilis diagnosis and treatment.
Main Results:
- Syphilis incidence has dramatically increased, particularly among women and men who have sex with women.
- Treatment options are limited by penicillin shortages and macrolide resistance.
- Current diagnostic tests have limitations in sensitivity and can cause delays.
Conclusions:
- Public health interventions, including doxycycline post-exposure prophylaxis, show promise in disease control.
- Serologic testing remains crucial for syphilis screening and diagnosis due to its cost-effectiveness and sensitivity.
- Investment in public health infrastructure, data sharing, and addressing social determinants are vital for reducing syphilis rates.

